Table 2.
|
Independent variable |
Dependent variable |
||||
---|---|---|---|---|---|---|
Formulation number | Glycolide content (X1;%) | Polymer concentration (X2;% w/v) | Drug-to-polymer ratio (X3) | Burst release (Y1;%) | Drug loading (Y2;% w/w) | Particle size (Y3; μm) |
1 | 0 | 3 | 0.15 | 16.8 | 10.5 | 2.4 |
2 | 50 | 9 | 0.2 | 18.7 | 10.35 | 3.1 |
3 | 25 | 15 | 0.2 | 14.65 | 15 | 2.4 |
4 | 50 | 9 | 0.1 | 19.4 | 8.7 | 2.8 |
5 | 25 | 3 | 0.1 | 23.6 | 6.4 | 1.6 |
6 | 25 | 9 | 0.15 | 15.89 | 11.4 | 1.8 |
7 | 25 | 9 | 0.15 | 15.89 | 11.4 | 1.8 |
8 | 50 | 15 | 0.15 | 13.8 | 12.4 | 3.1 |
9 | 25 | 3 | 0.2 | 19.65 | 6.8 | 2.4 |
10 | 0 | 9 | 0.2 | 16.4 | 15.1 | 2.7 |
11 | 25 | 9 | 0.15 | 15.89 | 11.4 | 1.8 |
12 | 0 | 15 | 0.15 | 12.8 | 11.6 | 3.7 |
13 | 50 | 3 | 0.15 | 24.9 | 4.5 | 3.5 |
14 | 0 | 9 | 0.1 | 13.8 | 8.7 | 3.2 |
15 | 25 | 15 | 0.1 | 12.7 | 9.2 | 3.6 |
This design was used to determine the influence of glycolide content, polymer concentration, and drug-to-polymer ratio on particle size, drug loading, and burst release for SAR 1118 microspheres.